ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 157 filers reported holding ASCENDIS PHARMA A/S in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $11,828,000 | +54.9% | 76,643 | +48.4% | 0.09% | +33.3% |
| Q2 2020 | $7,638,000 | +115.7% | 51,643 | +64.2% | 0.07% | +73.7% |
| Q1 2020 | $3,541,000 | -49.1% | 31,443 | -37.1% | 0.04% | -37.7% |
| Q4 2019 | $6,956,000 | +188.9% | 50,000 | +100.0% | 0.06% | +177.3% |
| Q3 2019 | $2,408,000 | -16.4% | 25,000 | 0.0% | 0.02% | -12.0% |
| Q2 2019 | $2,879,000 | -18.7% | 25,000 | -50.0% | 0.02% | -16.7% |
| Q3 2018 | $3,543,000 | +6.5% | 50,000 | 0.0% | 0.03% | +50.0% |
| Q2 2018 | $3,326,000 | +1.7% | 50,000 | 0.0% | 0.02% | -39.4% |
| Q1 2018 | $3,270,000 | +8.8% | 50,000 | -33.3% | 0.03% | +6.5% |
| Q4 2017 | $3,005,000 | – | 75,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 7,387,900 | $1,177,557,000 | 16.32% |
| Q Global Advisors, LLC | 66,714 | $10,634,000 | 8.85% |
| Ghost Tree Capital, LLC | 120,000 | $19,127,000 | 5.59% |
| Vivo Capital, LLC | 760,606 | $121,233,000 | 5.44% |
| Spyglass Capital Management LLC | 1,378,887 | $219,781,000 | 5.04% |
| Avoro Capital Advisors LLC | 1,980,000 | $315,592,000 | 4.96% |
| Eversept Partners, LP | 445,203 | $70,960,906 | 4.93% |
| Sofinnova Investments, Inc. | 499,824 | $79,667,000 | 4.72% |
| Eventide Asset Management | 1,748,648 | $278,717,000 | 3.68% |
| Baker Brothers Advisors | 4,541,604 | $723,886,000 | 3.18% |